Marshall Wace’s Cartesian Growth Corp II RENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-303,834
Closed -$3.24M 2598
2023
Q2
$3.24M Sell
303,834
-496,155
-62% -$5.25M 0.01% 1198
2023
Q1
$8.39M Hold
799,989
0.02% 775
2022
Q4
$8.21M Hold
799,989
0.02% 910
2022
Q3
$8.01M Buy
+799,989
New +$8.02M 0.02% 1051

Other funds holding RENE

Marshall Wace's RENE Position: Q3 2023 in Review

Marshall Wace sold out of Cartesian Growth Corp II (RENE) in Q3 2023, closing a stake of 303,834 shares — an estimated $3.24M sold.

Marshall Wace first reported a position in RENE in Q3 2022 and held it in 4 quarters. The position peaked at $8.39M in Q1 2023. 46 funds tracked by Wall St. Rank hold RENE as of Q3 2023.

  • Marshall Wace reported no remaining Cartesian Growth Corp II position as of Q3 2023 after selling out during the quarter.
  • Marshall Wace sold 303,834 Cartesian Growth Corp II shares in Q3 2023, an estimated $3.24M.
  • Marshall Wace first reported a position in Cartesian Growth Corp II in Q3 2022 and held it in 4 quarters.
  • Marshall Wace's Cartesian Growth Corp II position peaked at $8.39M in Q1 2023.
  • 46 funds tracked by Wall St. Rank held Cartesian Growth Corp II as of Q3 2023.

Based on Marshall Wace's 13F filing for Q3 2023, filed 14 Nov 2023.